A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors

Exclusion Criteria

• •Prior diagnosis of restless leg syndrome, periodic leg movement disorder, narcolepsy, or rapid eye movement (REM) behavior disorder
• •Current sleep apnea (treated or untreated)
• •Current shiftwork
• •Actively receiving chemotherapy or radiation (endocrine therapy permitted)
• •Previously received CBTi therapy with a professional therapist
• •Contraindications to CBTi including:
• •* Active psychosis
• •* Uncontrolled bipolar disorder
• •* Severe depression
• •* Active substance use disorder (moderate or greater severity)
• •Use of prescribed sleep medication \> 3 times per week
• •Previously participated in user testing of the study intervention (Cecebot)
• •Unwilling or unable to complete study procedures